Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine Efficacy for P. vivax Relapse Prevention in Ethiopia
NCT01680406Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Oct 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of primaquine in Plasmodium vivax malaria (4 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: P. vivax treatment failures at Day 42. Started Oct 2012; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01680406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680406.